Pectoralis and Serratus Nerve Blocks for Mastectomy: a Prospective, Randomized, Single-blind Trial

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Pectoral nerve block provides a good alternative to epidural or paravertebral block with a lower risk for the patient and that is shown as an optimal anesthetic option with reduction in postoperative pain, anesthetic and opioid consumption. The main objective of this study is to evaluate the quality of the perioperative analgesia of the PECS block in patients electively escalated for the accomplishment of mastectomy under general anesthesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Base
• Treatments: Anesthetics; Fentanyl; Sevoflurane

Criteria

Inclusion Criteria:

• Female patients, aged 18 to 60 years, electively scheduled to perform mastectomy in the Base Hospital of the Federal District;

• Physical State 1, 2 or 3 the American Society of Anesthesiology (ASA);

Exclusion Criteria:

• Patients with unstable angina

• Patient with poorly controlled asthma

• Substance abuse

• Heart failure, greater than first degree atrioventricular block

• Pregnant women

• Patients with allergy to dipyrone, morphine;

• Patients with chronic pain;

• Patients with severe hepatic disease;

• Patients with severe kidney disease;

• Patients with neurological diseases;

• Included patients in other clinical studies currently or in the past three months under general anesthesia;

• Patients who refuse to participate in the study;

• Any other condition that, in the opinion of the investigator, may pose a risk to the patient or interfere with the study objectives;